Trend
โ
Key levels
โ
Latest news & SEC filings
No headlines in the last 90 days.
ยท Healthcare
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for RPTX.
Start Free Trial โValuation Verdict
N/A
Methods Used
PEG
Fair Value
$1.65
23
Moat Score
NONE
3/9
Piotroski Score
-0.1
Altman Z-Score
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
DISTRIBUTING
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Insider trades, congress trades, institutional flows, and short interest โ updated daily with real-time alerts.
See All Smart Money Signals โRevenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
10.31%
FCF Growth YoY
40.8%
Revenue Trend
UNKNOWN
SEPT's Trading AI has generated a free, downloadable PDF research report for Repare Therapeutics Inc. (RPTX) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (0 articles analyzed), and SEC filing intelligence...
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days โRPTX last reported on Mar 2, 2026: EPS -$0.67 vs -$0.29 expected โ a miss of 131.0%.
RPTX does not currently pay a dividend.
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.